Cancer accounts for more than onequarter of new drug approvals analysis finds

Cancer accounts for more than one-quarter of new drug approvals, analysis finds

Overall, the report, from the Tufts Center for the Study of Drug Development, found that new cancer drug approvals since 2010 have increased by 4 percent since the 1980s.

More From BioPortfolio on "Cancer accounts for more than one-quarter of new drug approvals, analysis finds"